国家神经系统疾病临床医学研究中心数据管理与共享系统

Data Management And Sharing System of China National Clinical Research Center for Neurological Diseases

Serum 25-hydroxyvitamin D and the risk of cardiovascular disease: dose-response meta-analysis of prospective studies

第一作者:Runhua Zhang

通讯作者:Gaifen Liu

25-hydroxyvitamin D cardiovascular disease metaa

基本信息

  • 负责人:Runhua Zhang
  • 数据来源: OTHERS
  • 论文编号:OTHERS20190064
  • 发表时间:2017-04-01

2017-04-01

已发表文章

发表杂志:American Journal of Clinial Nurtrition

发表类型: Original Contributions

影响因子(IF): 6.926

PMID: 28251933 Pubmed原文链接 全文下载

主要研究背景及目的

During the past decade, an increasing number of prospective studies have focused on the association between vitamin D and cardiovascular disease (CVD). However, the evidence on the relation between serum 25-hydroxyvitamin D [25(OH)D] and the risk of overt CVD is inconclusive. We performed a dose-response meta-analysis to summarize and prospectively quantify the RR of low serum 25(OH)D concentration and total CVD (events and mortality).

方法

We identified relevant studies by searching PubMed and EMBASE up to December 2015 and by hand-searching reference lists. Prospective studies based on the general population and reported RRs and 95% CIs were included. A random-effects model was used to calculate the pooled RRs. Nonlinear association was assessed by using restricted cubic spline analyses.

结论

Serum 25(OH)D concentration was inversely associated with total CVD events and CVD mortality from the observed studies.

主要结果

A total of 34 publications with 180,667 participants were eligible for the meta-analysis. We included 32 publications (27 independent studies) for total CVD events and 17 publications (17 independent studies) for CVD mortality. We observed an inverse association between serum 25(OH)D and total CVD events and CVD mortality, and the pooled RRs per 10-ng/mL increment were 0.90 (95% CI: 0.86, 0.94) for total CVD events and 0.88 (95% CI: 0.80, 0.96) for CVD mortality. A nonlinear association was detected for total CVD events (P-nonlinear , 0.001) and CVD mortality (P-nonlinear = 0.022).